There are several recent examples where clinically significant, safety-related, drug effects on hemodynamics or cardiac function were not apparent until large clinical trials were completed or the drugs entered the consumer market.
Cardiovascular Function in Nonclinical Drug Safety Assessment Current Issues and Opportunities
International Journal of Toxicology, 2011